(Q34626471)

3 August 2017

IMS updated recommendations on postmenopausal hormone therapy (English)

1 reference

3 August 2017

6

Marco Gambacciani

1 reference

3 August 2017

Board of the International Menopause Society

1

1 reference

3 August 2017

Amos Pines

2

1 reference

3 August 2017

David W Sturdee

3

1 reference

3 August 2017

Martin H Birkhäuser

4

1 reference

3 August 2017

Hermann P G Schneider

5

1 reference

3 August 2017

Nick Panay

7

1 reference

3 August 2017

1 June 2007

1 reference

3 August 2017

1 reference

3 August 2017

10

1 reference

3 August 2017

181-194

1 reference

3 August 2017

3

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

3 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Exercise for health for early postmenopausal women: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Health benefits of physical activity: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Direct transport of progesterone from vagina to uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Intrauterine application of progestins in hormone replacement therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Estrogen exposures and memory at midlife: a population-based study of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Hormone therapy and cerebrovascular events: a population-based nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Introduction to special issue on women's sexuality and outline of assessment of sexual problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Menopause and aging, quality of life and sexuality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

A New Approach to the Development of Assessment Guidelines for Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701361657

10.1080/13697130701361657

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference